Enteropathy-associated T-cell lymphoma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Nima Nasiri (talk | contribs) No edit summary |
||
| (56 intermediate revisions by 4 users not shown) | |||
| Line 5: | Line 5: | ||
{{Enteropathy-associated T-cell lymphoma}} | {{Enteropathy-associated T-cell lymphoma}} | ||
{{CMG}}; {{AE}} {{ | {{CMG}}; {{AE}} {{Nnasiri}} | ||
{{SK}} Enteropathy-type T-cell lymphoma; Intestinal T-cell lymphoma; EATL; ETTL | |||
==[[Enteropathy-associated T-cell lymphoma overview|Overview]]== | ==[[Enteropathy-associated T-cell lymphoma overview|Overview]]== | ||
==[[Enteropathy-associated T-cell lymphoma historical perspective|Historical | == [[Enteropathy-associated T-cell lymphoma historical perspective|Historical perspective]] == | ||
==[[Enteropathy-associated T-cell lymphoma classification|Classification]]== | == [[Enteropathy-associated T-cell lymphoma classification|Classification]] == | ||
==[[Enteropathy-associated T-cell lymphoma pathophysiology|Pathophysiology]]== | ==[[Enteropathy-associated T-cell lymphoma pathophysiology|Pathophysiology]]== | ||
| Line 18: | Line 19: | ||
==[[Enteropathy-associated T-cell lymphoma causes|Causes]]== | ==[[Enteropathy-associated T-cell lymphoma causes|Causes]]== | ||
==[[Enteropathy-associated T-cell lymphoma differential diagnosis|Differentiating Enteropathy-associated T-cell lymphoma from | ==[[Enteropathy-associated T-cell lymphoma differential diagnosis|Differentiating Enteropathy-associated T-cell lymphoma from Other Diseases]]== | ||
==[[Enteropathy-associated T-cell lymphoma epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Enteropathy-associated T-cell lymphoma epidemiology and demographics|Epidemiology and Demographics]]== | ||
| Line 28: | Line 29: | ||
==[[Enteropathy-associated T-cell lymphoma natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ==[[Enteropathy-associated T-cell lymphoma natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
== | ==Diagnostic criteria== | ||
[[ | |||
[[Diagnostic criteria|Diagnostic Criteria]] | [[Enteropathy-associated T-cell lymphoma history and symptoms|History and Symptoms]] | [[Enteropathy-associated T-cell lymphoma physical examination|Physical Examination]] | [[Enteropathy-associated T-cell lymphoma laboratory findings|Laboratory Findings]] | [[Enteropathy-associated T-cell lymphoma electrocardiogram|Electrocardiogram]] | [[Enteropathy-associated T-cell lymphoma x ray|X Ray]] | [[Enteropathy-associated T-cell lymphoma CT|CT]] | [[Enteropathy-associated T-cell lymphoma MRI|MRI]] | [[Enteropathy-associated T-cell lymphoma echocardiography and ultrasound|Echocardiography or Ultrasound]] | [[Enteropathy-associated T-cell lymphoma other imaging findings|Other Imaging Findings]] | [[Enteropathy-associated T-cell lymphoma other diagnostic studies|Other Diagnostic Studies]] | |||
==Treatment== | ==Treatment== | ||
[[Enteropathy-associated T-cell lymphoma medical therapy|Medical Therapy]] | [[Enteropathy-associated T-cell lymphoma surgery|Surgery]] | [[Enteropathy-associated T-cell lymphoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | | [[Enteropathy-associated T-cell lymphoma medical therapy|Medical Therapy]] | [[Enteropathy-associated T-cell lymphoma surgery |Surgery]] | [[Enteropathy-associated T-cell lymphoma primary prevention|Primary Prevention]] | [[Enteropathy-associated T-cell lymphoma secondary prevention|Secondary Prevention]] | [[Enteropathy-associated T-cell lymphoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Enteropathy-associated T-cell lymphoma future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
[[Enteropathy-associated T-cell lymphoma case study one|Case #1]] | [[Enteropathy-associated T-cell lymphoma case study one|Case #1]] | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Up-To-Date]] | |||
[[Category: | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
[[Category:Gastroenterology]] | |||
Latest revision as of 17:25, 6 March 2019
For patient information, click here
|
Enteropathy-associated T-cell lymphoma Microchapters |
|
Differentiating Enteropathy-associated T-cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Enteropathy-associated T-cell lymphoma On the Web |
|
American Roentgen Ray Society Images of Enteropathy-associated T-cell lymphoma |
|
Risk calculators and risk factors for Enteropathy-associated T-cell lymphoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]
Synonyms and keywords: Enteropathy-type T-cell lymphoma; Intestinal T-cell lymphoma; EATL; ETTL
Overview
Historical perspective
Classification
Pathophysiology
Causes
Differentiating Enteropathy-associated T-cell lymphoma from Other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnostic criteria
Diagnostic Criteria | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies